Core One Labs Inc C.COOL

Alternate Symbol(s): CLABF

Healthcare Cannabis Psychedelics

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.

CSE:COOL - Post by User

Core One Labs Inc

Bullboard Posts

Comment by Leafs4Lifeon Nov 06, 2018 10:57pm

74 Views

Post# 28934862

RE:What is this Form No.7

It's a monthly progress filing that is mandatory for companies listed on the CSE. Reporting revenue is not mandatory in this filing but LDS has chosen to report this way (in addition to financials on the 29th)

KingShare wrote:

Also if you see LDS usually post the results of quarter November 29th. They have been filing in Sedar for 2016,2017 near end of November for the results. They are very consistent.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal